15,266 Shares in Smith & Nephew SNATS, Inc. $SNN Bought by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. purchased a new position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,266 shares of the medical equipment provider's stock, valued at approximately $433,000.

Other institutional investors have also bought and sold shares of the company. Hexagon Capital Partners LLC grew its holdings in Smith & Nephew SNATS by 63.3% during the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock worth $30,000 after buying an additional 406 shares in the last quarter. Richards Merrill & Peterson Inc. grew its holdings in Smith & Nephew SNATS by 500.0% during the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock worth $34,000 after buying an additional 1,000 shares in the last quarter. Bessemer Group Inc. grew its holdings in Smith & Nephew SNATS by 3,471.4% during the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock worth $49,000 after buying an additional 1,701 shares in the last quarter. Hara Capital LLC grew its holdings in Smith & Nephew SNATS by 391.4% during the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after buying an additional 1,957 shares in the last quarter. Finally, Opal Wealth Advisors LLC bought a new stake in Smith & Nephew SNATS during the first quarter worth $73,000. Institutional investors own 25.64% of the company's stock.

Smith & Nephew SNATS Trading Down 1.1%

Shares of Smith & Nephew SNATS stock opened at $36.20 on Monday. Smith & Nephew SNATS, Inc. has a 1 year low of $23.69 and a 1 year high of $36.84. The firm has a market cap of $15.85 billion, a PE ratio of 16.76, a P/E/G ratio of 1.00 and a beta of 0.68. The stock has a fifty day moving average price of $31.24 and a 200-day moving average price of $28.87. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40.

Smith & Nephew SNATS Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 3rd will be paid a dividend of $0.285 per share. The ex-dividend date is Friday, October 3rd. This represents a dividend yield of 210.0%. Smith & Nephew SNATS's dividend payout ratio is presently 41.20%.

Analysts Set New Price Targets

Several brokerages recently issued reports on SNN. Canaccord Genuity Group upped their price target on Smith & Nephew SNATS from $27.00 to $28.00 and gave the stock a "hold" rating in a report on Thursday, May 1st. HSBC lowered Smith & Nephew SNATS from a "buy" rating to a "hold" rating in a research report on Friday, April 25th. Finally, Hsbc Global Res lowered Smith & Nephew SNATS from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Six research analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $28.00.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.